A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

计划入组 54 人 · 首次发布于 2025 年 1 月 23 日

Evaluating How Well Different Types of Light-sensitive Cells in the Eye Contribute to Its Focusing Ability

计划入组 20 人 · 首次发布于 2026 年 7 月 9 日

Wearable Dark-adaptometer in Normal Adult Healthy Volunteers

计划入组 20 人 · 首次发布于 2016 年 2 月 4 日

photoreceptor rescue cell therapy

Photoreceptor cell therapy (BlueRock)

PNC-1

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

KLSMC Stem Cells, Inc.

CIRM Awards $4.7 Million to Advance AAV Gene Therapy for Blue Cone Monochromacy

BlueRock Therapeutics' OpCT-001 Receives FDA Clearance for Phase I/IIa Trial in Primary Photoreceptor Diseases

FDA Grants Fast Track Status to BlueRock's Novel Cell Therapy for Inherited Retinal Diseases